BMX-IN-1
1431525-23-3
0.982%
2026-07-04
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Description
ProductName BMX-IN-1 Cat No CEI-1258 Description BMX-IN-1 is a highly selective and potent irreversible inhibitor of BMX kinase. Product Overview BMX-IN-1 is a highly selective and irreversible inhibitor of BMX kinase. BMX, also known as ETK, is a member of Tec family and plays an important role in regulating ischemia-mediated arteriogenesis and lymphangiogenesis. BMX is mainly expressed in arterial endothelia and in myeloid hematopoietic cells and it has been reported that BMX involves in tumor growth. BMX-IN-1 is a potent BMX kinase inhibitor and has an irreversible function on BMX kinase. When tested with prostate cancer cell lines, BMX-IN-1 treatment inhibited the proliferation of Tel-BMX-transformed Ba/F3 cells at lowdose. CAS No 1431525-23-3 Molecular Weight 524.59 Purity 0.982 Storage Store at -20°C Synonyms BMX kinase inhibitor Targets BMX kinase Molecular Formula C29H24N4O4S Chemical Name N-[5-[9-[4-(methanesulfonamido)phenyl]-2-oxobenzo[h][1,6]naphthyridin-1-yl]-2-methylphenyl]prop-2-enamide Solubility Soluble in DMSO Shipping Conditions Evaluation sample solution: ship with blue ice. All other available size: ship with RT, or blue ice upon request category Inhibitors(c1514) cas_num 1431525-23-3 Basic Info-
Product Name:
BMX-IN-1
Other Name:BMX kinase inhibitor;BMX-IN-1;N-(2-Methyl-5-(9-(4-(MethylsulfonaMido)phenyl)-2-oxobenzo[h][1,6]naphthyridin-1(2H)-yl)phenyl)acrylaMide;N-[2-Methyl-5-[9-[4-[(methylsulfonyl)amino]phenyl]-2-oxobenzo[h]-1,6-naphthyridin-1(2H)-yl]phenyl]-2-propenamide;henyl]-
CAS No.:1431525-23-3
Molecular Formula:C29H24N4O4S
InChIKeys:SFMJNHNUOVADRW-UHFFFAOYSA-N
Molecular Weight:524.59026
Exact Mass:524.151855
Categories:
Characteristics-
PSA:
117
XLogP3:3.52
Density:1.4±0.1 g/cm3
Refractive Index:1.708
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product